Compile Data Set for Download or QSAR
Report error Found 184 Enz. Inhib. hit(s) with all data for entry = 2134
LigandPNGBDBM355759(US9815832, 36 | 3-(4-Chloro-3,5-difluorophenyl)-N-...)
Affinity DataIC50: 5.65nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355753(US9815832, 30 | N-Cyclopropyl-3-(3,4,5-trifluoroph...)
Affinity DataIC50: 5.77nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355750(US9815832, 27 | N-Cyclopropyl-3-(3,4-dichloropheny...)
Affinity DataIC50: 12.2nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355743(US9815832, 20 | 3-(4-Cyano-3,5-difluorophenyl)-N-c...)
Affinity DataIC50: 13.8nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355732(US9815832, 9 | Azetidin-1-yl[3-(4-chloro-3,5-diflu...)
Affinity DataIC50: 14.2nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355733(US9815832, 10 | Azetidin-1-yl[3-(4-chloro-3-fluoro...)
Affinity DataIC50: 15.2nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355755(US9815832, 32 | 3-(3-Chloro-4-fluorophenyl)-N-cycl...)
Affinity DataIC50: 15.7nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355756(US9815832, 33 | 3-(3-Chloro-4-methylphenyl)-N-cycl...)
Affinity DataIC50: 15.9nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355731(US9815832, 8 | 4-[2-(Azetidin-1-ylcarbonyl)-3H-imi...)
Affinity DataIC50: 16nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355726(US9815832, 4 | 3-(4-Chloro-3-fluorophenyl)-N-cyclo...)
Affinity DataIC50: 18.4nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355723(US9815832, 1 | N-Cyclopropyl-3-(3-fluoro-4-methylp...)
Affinity DataIC50: 31.8nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355785(US9815832, 62 | N-Cyclopropyl-3-(3,4-difluoropheny...)
Affinity DataIC50: 34.9nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355729(US9815832, 6 | 3-(4-Chloro-3-fluorophenyl)-N-propy...)
Affinity DataIC50: 38.1nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355730(US9815832, 7 | 3-(4-Cyano-3-fluorophenyl)-N-cyclop...)
Affinity DataIC50: 40.8nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355795(US9815832, 72 | N-Cyclopropyl-3-[3-(methylsulfanyl...)
Affinity DataIC50: 40.9nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355744(US9815832, 21 | [3-(4-Chloro-3-fluorophenyl)-3H-im...)
Affinity DataIC50: 42.6nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355741(US9815832, 18 | Azetidin-1-yl[3-(3-fluoro-4-methyl...)
Affinity DataIC50: 48.7nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355728(US9815832, 5 | 3-(4-Chloro-3-fluorophenyl)-N-(1-me...)
Affinity DataIC50: 54.1nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355797(US9815832, 74 | 3-(4-Chloro-3-methylphenyl)-N-cycl...)
Affinity DataIC50: 58.8nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355786(US9815832, 63 | N-Cyclopropyl-3-(3,5-dichloropheny...)
Affinity DataIC50: 68nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355792(US9815832, 69 | 3-(3-Chlorophenyl)-N-cyclopropyl-3...)
Affinity DataIC50: 70.9nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355754(US9815832, 31 | 3-(3-Cyano-4-fluorophenyl)-N-cyclo...)
Affinity DataIC50: 87.5nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355771(US9815832, 48 | N-Cyclopropyl-3-(3,5-difluoropheny...)
Affinity DataIC50: 88.9nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355735(US9815832, 12 | Azetidin-1-yl[3-(4-chloro-2,5-difl...)
Affinity DataIC50: 99.4nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355764(US9815832, 41 | 3-(4-Chloro-2,5-difluorophenyl)-N-...)
Affinity DataIC50: 100nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355802(US9815832, 79 | 3-(5-Chloro-2-fluorophenyl)-N-cycl...)
Affinity DataIC50: 106nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355751(US9815832, 28 | N-Cyclopropyl-3-(4-fluoro-3-methyl...)
Affinity DataIC50: 114nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355725(US9815832, 3 | 3-(4-Chlorophenyl)-N-cyclopropyl-3H...)
Affinity DataIC50: 131nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355794(US9815832, 71 | 3-(1,3-Benzothiazol-6-yl)-N-cyclop...)
Affinity DataIC50: 155nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355779(US9815832, 56 | 3-(3-Cyano-4-methylphenyl)-N-cyclo...)
Affinity DataIC50: 167nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355788(US9815832, 65 | N-Cyclopropyl-3-(3-fluorophenyl)-3...)
Affinity DataIC50: 188nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355739(US9815832, 16 | Azetidin-1-yl[3-(4-chlorophenyl)-3...)
Affinity DataIC50: 196nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355768(US9815832, 45 | N-Cyclopropyl-3-(3-fluoro-4-methox...)
Affinity DataIC50: 205nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355787(US9815832, 64 | N-Cyclopropyl-3-(2,3-dihydro-1H-in...)
Affinity DataIC50: 206nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355774(US9815832, 51 | N-Cyclopropyl-3-(4-methoxy-3-methy...)
Affinity DataIC50: 207nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355747(US9815832, 24 | 3-(4-Chlorophenyl)-N-(1-methyl-1H-...)
Affinity DataIC50: 211nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355791(US9815832, 68 | N-Cyclopropyl-3-(4-fluorophenyl)-3...)
Affinity DataIC50: 219nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355752(US9815832, 29 | N-Cyclopropyl-3-(4-methylphenyl)-3...)
Affinity DataIC50: 225nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355759(US9815832, 36 | 3-(4-Chloro-3,5-difluorophenyl)-N-...)
Affinity DataIC50: 255nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355743(US9815832, 20 | 3-(4-Cyano-3,5-difluorophenyl)-N-c...)
Affinity DataIC50: 262nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355775(US9815832, 52 | N-Cyclopropyl-3-(3,4-dimethylpheny...)
Affinity DataIC50: 271nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355745(US9815832, 22 | Azetidin-1-yl[3-(4-chloro-2-fluoro...)
Affinity DataIC50: 273nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355765(US9815832, 42 | 3-(4-Cyanophenyl)-N-cyclopropyl-3H...)
Affinity DataIC50: 276nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355742(US9815832, 19 | (3-Fluoroazetidin-1-yl)[3-(3-fluor...)
Affinity DataIC50: 281nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355776(US9815832, 53 | 3-(3-Cyanophenyl)-N-cyclopropyl-3H...)
Affinity DataIC50: 287nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355778(US9815832, 55 | N-Cyclopropyl-3-(4-fluoro-3-methox...)
Affinity DataIC50: 304nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355744(US9815832, 21 | [3-(4-Chloro-3-fluorophenyl)-3H-im...)
Affinity DataIC50: 316nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355749(US9815832, 26 | 3-(4-Chloro-2-methylphenyl)-N-cycl...)
Affinity DataIC50: 319nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355769(US9815832, 46 | N-Cyclopropyl-3-(3-methoxyphenyl)-...)
Affinity DataIC50: 329nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

LigandPNGBDBM355777(US9815832, 54 | 3-(5-Chloro-2-methylphenyl)-N-cycl...)
Affinity DataIC50: 329nMAssay Description:The PDE4B and 4D assays use scintillation proximity assay (SPA) technology to measure the inhibition of human recombinant PDE4B and PDE4D enzyme acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent

Displayed 1 to 50 (of 184 total ) | Next | Last >>
Jump to: